Is ResMed Inc. (RMD) a Buy, Sell, or Hold?
NYSE : RMD
ResMed Inc.
$192.91 USD
-$2.89 (-1.48%)
- Volume
- 754.4K
- Average Volume
- 1.56M
- Market Capitalization
- $27.98B
- P/E Ratio
- 18.58
- Dividend Yield
- 1.24%
- Price Target
- $234.00
- Year High
- $293.81
- Year Low
- $180.27
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.22
- Current Ratio
- $3.01
Company Overview
NYSE
Michael J. Farrell
Medical - Devices
Healthcare
RMD
10600
US
USD
Liquidity Metrics
0.13
3.01
2.33
1.23
0.22
Sales & Valuation
$5.15B
5.05
4.35
16.01
11.94
Profitability
$9.51
$1.4B
27.44%
34.37%
24.41%
17.30%
P/E Metrics
18.58
1.16
1.16
Analyst Price Target & Rating
$234.00
$300.00
$220.00
4/5
35 Analysts
-17.56%
Financial Health Scores
10.39
7/9
$2.71B
$8.78B
$2.29B
$1.93B
Key Metrics (TTM)
$28B
5.06
12.81
3.01
24.41%
19.63%
5.22%
6.07%
$101.71
179 days
Company Executives
| Name | Title |
|---|---|
| Brett A. Sandercock | Advisor |
| Justin Leong | Chief Product Officer |
| Sallilyn Schwartz | Chief Investor Relations Officer |
| Yvonne-Katrin Pucknat | Chief Marketing Officer |
| Michael Rider | Chief Legal Officer & Secretary |
| Michael J. Farrell | Chief Executive Officer & Chairman |
| Jim Ellis | Chief Compliance Officer |
| Aaron Bloomer | Chief Financial Officer |
| Peter C. Farrell | Founder, Chair Emeritus & Non-Executive Director |
| Alastair Robertson | Chief Information Officer |
Poll Results
No votes yet today — be the first to share your view!
About ResMed Inc. (NYSE:RMD) Stock
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setti ... ng adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
2026-07-21 16:40:00
TROY, Mich., July 21, 2026 /PRNewswire/ -- The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Broadridge Financial Resources Inc. (NYSE: BR) as its "Stock to Study" and ResMed Inc. (NYSE: RMD) as its "Undervalued Stock" in the October 2026 issue for investors' informational and educational use.
Baader Bank Aktiengesellschaft Trims Position in ResMed Inc. $RMD
2026-07-21 04:01:02
Baader Bank Aktiengesellschaft decreased its stake in shares of ResMed Inc. (NYSE: RMD) by 61.7% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,768 shares of the medical equipment provider's stock after selling 7,696 shares during the quarter. Baader
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
2026-07-13 09:56:21
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Resmed Divests MatrixCare Business to Sharpen Focus on Connected Care
2026-07-10 13:56:05
RMD's MatrixCare sale sharpens its focus on sleep, breathing and connected care while freeing resources for AI-powered digital health.
ResMed Analyst Backs Portfolio Reset
2026-07-09 14:03:51
ResMed Inc. (NYSE:RMD) agreed to sell its MatrixCare business on Tuesday to Frazier Healthcare Partners, a private equity firm focused exclusively on health care, for $490 million.
Why ResMed (RMD) is a Top Momentum Stock for the Long-Term
2026-07-08 10:51:05
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Top 50 High-Quality Dividend Growth Stocks For July 2026
2026-07-08 07:42:40
I track a curated universe of 50 high-quality dividend growth stocks to identify opportune entry points based on valuation and future return potential. Year-to-date through June, the investable universe returned 8.69%, trailing SPY (10.10%) and SCHD (17.50%), but several individual stocks outperformed significantly. Currently, 39 out of 50 stocks offer a forward return estimate of at least 10%, with 22 appearing potentially undervalued by my free cash flow model.
ResMed to sell software business MatrixCare for $490 million
2026-07-07 18:07:23
ResMed said on Tuesday it would sell its software business MatrixCare to private equity firm Frazier Healthcare Partners for $490 million in cash, as the health technology company sharpens its focus on sleep, breathing and home-based care.
Frequently Asked Questions
-
What is the current ResMed Inc. (RMD) stock price?
-
ResMed Inc.(NYSE:RMD) stock price is $192.91 in the last trading session. During the trading session, RMD stock reached the peak price of $293.81 while $180.27 was the lowest point it dropped to. The percentage change in RMD stock occurred in the recent session was --1.48% while the dollar amount for the price change in RMD stock was -$2.89.
-
RMD's industry and sector of operation?
-
The NYSE listed RMD is part of Medical - Devices industry that operates in the broader Healthcare sector.
-
Who are the executives of RMD?
-
Brett A. Sandercock | Advisor
Justin Leong | Chief Product Officer
Sallilyn Schwartz | Chief Investor Relations Officer
Yvonne-Katrin Pucknat | Chief Marketing Officer
Michael Rider | Chief Legal Officer & Secretary -
How many employees does RMD have?
-
Number of RMD employees currently stands at 10600. RMD operates from 9001 Spectrum Center Boulevard, San Diego, CA 92123, US.
-
Link for RMD official website?
-
Official Website of RMD is: https://www.resmed.com
-
How do I contact RMD?
-
RMD could be contacted at phone #858 836 5000 and can also be accessed through its website. RMD operates from 9001 Spectrum Center Boulevard, San Diego, CA 92123, US.
-
How many shares of RMD are traded daily?
-
The average number of RMD shares traded daily for last 3 months was 1.56M.
-
What is the market cap of RMD currently?
-
The market value of RMD currently stands at $27.98B with its latest stock price at $192.91